Authors


Fuller Currie, PharmD candidate

Latest:

Opinion: Coronavirus Impact on Pharmacy Students in APPE Rotations

Three student pharmacists share their experiences adapting to APPE rotations during the COVID-19 pandemic,


Tetine Sentell, PhD

Latest:

Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs

Total cost of care for patients whose glycated hemoglobin levels were


Kenneth S. O'Rourke, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Amanda Daniels, PharmD

Latest:

Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 Diabetes

Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.



Heather Steelman Coleman, PharmD

Latest:

Case Report: Congestive Heart Failure

The patient's heart failure needs to be classified to determine the appropriate treatment strategy.


Loriann De Martini, PharmD, MPH, BCGP

Latest:

Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.



Caitlin Mollison

Latest:

Celebrating Black History Month: 5 Trailblazing Pharmacists

There are many pharmacy pioneers, both known and unknown, but here we spotlight standouts who made early contributions to the profession.


Brian Nightengale, PhD

Latest:

Review of Outcomes Associated With Formulary Restrictions: Focus on Step Therapy

As healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.


Amy Kennedy, PharmD, BCACP

Latest:

COVID-19 Pandemic and Adherence to Therapy: What Can Pharmacists Do?

It is likely that in the coronavirus disease 2019 era and its aftermath, we may see worsening adherence to therapy due to known factors that affect adherence and others that are unique to what is happening currently.


Marie-Helene Meikengang Njomene, PharmD Candidate

Latest:

Balancing Pharmacy School and Parenthood

Any woman who has tried being both a full-time mother and a full-time student can tell you that is not an easy task.


Chris J. Meyer, PharmD, RPh

Latest:

Going Toe-to-Toe With the Goliaths

Our pharmacy is the underdog when it comes to big business, but there are tricks to help attract customers and keep ourselves in the game with the Goliath chains.


Andy Crawford

Latest:

Why Generics Matter More Than Ever Before in Today’s Specialty Pharmacies

Many pharmacies may be missing significant, profitable opportunities...via generic pharmaceuticals.


Shelly Spiro, RPh, FASCP

Latest:

SNOMED CT Is Coming to Pharmacy: A Primer on Systematized Nomenclature of Medicine "Clinical Terms" Documentation (for Pharmacist and Pharmacy Services)

Ideally, pharmacists document clinical or progress notes where important assessments and findings are assigned specific codes to capture and measure the value of the clinical care they provide.


Victor J. Lewis, PharmD

Latest:

High Blood Pressure: Getting the Most Out of Home Monitoring

Dr. Lewis is a pharmacy practice resident at University of Colorado (UC) Hospital. Dr. Page is an associate professor of clinical pharmacy and physical medicine and a clinical specialist, Division of Cardiology, UC Health Sciences Center, Schools of Pharmacy and Medicine.


David Hughes, PharmD, BCOP

Latest:

Getting in the Mindset to Become a Successful Preceptor: How to Precept Responsibly

Students should prepare to be preceptors early in their pharmacy school careers.


Tara Petersen, Pharmacy Times Editorial Director

Latest:

Promise or Peril? Collaboration in Pharmacy

Coordination of patient care is a key goal of the accountable care organization model.


Jen Whartenby, Associate Editor

Latest:

WHO Reports on Impact of the 2009 H1N1 Flu Season

Pregnant women and obese individuals were much more likely to become severely ill from exposure to the H1N1 virus compared with the general population, according to a new WHO report.


Herb Steward, BSc, MBA

Latest:

Initiating an Antimicrobial Stewardship Program: The Costs and the Benefits

For decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.


Yunes Doleh, PharmD candidate

Latest:

Case Studies (May 2015)

What should these pharmacists do?


Susan Cornell, PharmD, CDE, FAPhA, FAADE

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.



Matthew Farber

Latest:

The Intersection of Technology and Cancer Care: The Opportunity and Implications for Specialty Pharmacy

Technological advancements empower patients to manage their own health.


Todd Brothers, PharmD, BCCCP, BCPS

Latest:

Pharmacist Management of Hyperkalemia: A Focus on Improving Clinical Outcomes

During the 2020 virtual Directions in Pharmacy® conference, Todd Brothers, PharmD, BCCCP, BCPS, presented a comprehensive overview of hyperkalemia to optimize patient care with the use of safe and effective pharmacotherapeutic agents.


Fred Eckel, Editor-in-Chief, Pharmacy Times

Latest:

Health Care Reform: A Game Changer

Health Care Reform is here, right? That is true on one level, in that President Obama has signed a health care bill into law. But the signing of the bill only begins the process of change.


Peter E. Modica, MA

Latest:

Patient Adherence: Identifying Barriers and Defining Solutions

Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.



Douglas C. A. Taylor, MBA

Latest:

Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving Chemotherapy

For US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.


Paul Varma

Latest:

Rx Product News Profile: A closer look at new FDA actions: Novartis' Valturna

The FDA has approved Valturna (aliskiren/valsartan) to treat hypertension.